10.02.2013 Views

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(C07K) II.1(1)<br />

• PROTEINES MUTANTES DE L'INTERFE-<br />

RON ET LEUR UTILISATION<br />

(73) KABUSHIKI KAISHA HAYASHIBARA SEI-<br />

BUTSU KAGAKU KENKYUJO, 2-3 Shimoishii,<br />

1-chome, Okayama-shi, Okayama 700-0907,<br />

JP<br />

Mayumi, Tadanori, Gurasuarina-Nishijin-<br />

Chuo 907, 1-1, Kojidai 5-chome, Nishi-ku,<br />

Kobe-shi, Hyogo 6512273, JP<br />

Tsutsumi, Yasuo, 20-1, Shinkohudai 2chome,<br />

Toyono-cho, Toyono-gun, Osaka<br />

563-0<strong>10</strong>5, JP<br />

Nakagawa, Shinsaku, 4-1, Nishikinomoto 4chome,<br />

Yao-shi, Osaka 581-0045, JP<br />

(72) TANIAI, Madoka, K.K. HAYASHIBARA SEI-<br />

BUTSU KAGAKU KENKYUJO, Okayama-shi,<br />

Okayama 7000907, JP<br />

TORIGOE, Kakuji, K.K.HAYASHIBARA SEI-<br />

BUTSU KAGAKU KEN., Okayama-shi,<br />

Okayama 700-0907, JP<br />

KURIMOTO, Masashi, K.K. HAYASHIBARA<br />

SEIBUTSU KAGAKU KENKYUJO, Okayamashi,<br />

Okayama 7000907, JP<br />

(74) Daniels, Jeffrey Nicholas, Page White &<br />

Farrer Bedford House, John Street London<br />

WC1N 2BF, GB<br />

(51) C07K 14/565 (11) 1 828 242 B1<br />

C12N 1/20<br />

(25) En (26) En<br />

(21) 05849877.5 (22) 19.12.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK YU<br />

(43) 05.09.2007<br />

(86) IN 2005/000419 19.12.2005<br />

(87) WO 2006/067804 2006/26 29.06.2006<br />

(30) 20.12.2004 IN MU13702004<br />

(54) • VERFAHREN ZUR HERSTELLUNG VON<br />

HOHEN NIVEAUS VON INTERFERON-BETA<br />

• PROCESS FOR PREPARING HIGH LEVELS<br />

OF INTERFERON BETA<br />

• PROCEDE DE PREPARATION DE NIVEAUX<br />

ELEVES D'INTERFERON BETA<br />

(73) CADILA HEALTHCARE LIMITED, Zydus<br />

Tower, Satellite Cross Roads, Gandhinagar-<br />

Sarkhej Highway, Ahmedebad 380 015,<br />

Gujarat, IN<br />

(72) MENDIRATTA, Sanjeev K. Cadila Healthcare<br />

Limited, Ahmedabad 380 015, Gujarat, IN<br />

SARASWAT, Vibhor, Cadila Healthcare Limited,<br />

Ahmedabad 380 015, Gujarat, IN<br />

CHUDASAMA, Dharmedra, Cadila Healthcare<br />

Limited, Ahmedabad 380 015, Gujarat, IN<br />

(74) Rigby, Barbara Nicole, et al, Dehns St Bride's<br />

House <strong>10</strong> Salisbury Square, London EC4Y<br />

8JD, GB<br />

C07K 14/575 → (51) A61K 38/02<br />

C07K 14/705 → (51) C12N 15/12<br />

(51) C07K 14/79 (11) 1 966 240 B1<br />

C07K 14/47<br />

(25) En (26) En<br />

(21) 06806526.7 (22) 25.<strong>10</strong>.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) <strong>10</strong>.09.2008<br />

(86) EP 2006/0<strong>10</strong>271 25.<strong>10</strong>.2006<br />

(87) WO 2007/076904 2007/28 12.07.2007<br />

(30) 30.12.2005 EP 05028755<br />

(54) • LACTOFERRIN-PEPTIDE, GEEIGNET ALS<br />

IN DIE ZELLE EINDRINGENDE PEPTIDE<br />

• LACTOFERRIN PEPTIDES USEFUL AS<br />

CELL-PENETRATING PEPTIDES<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• PEPTIDES DÉRIVÉS DE LA LACTOFER-<br />

RINE CAPABLES DE PÉNEÉTRER DANS<br />

LES CELLULES.<br />

(73) Evonik Röhm GmbH, Kirschenallee, 64293<br />

Darmstadt, DE<br />

(72) BROCK, Roland, 47533 Kleve, DE<br />

FISCHER, Rainer, 80796 München, DE<br />

FOTIN-MLECZEK Mariola, 7<strong>10</strong>65 Sindelfingen,<br />

DE<br />

HUFNAGEL Hansjörg, 82319 Söcking, DE<br />

WINDHAB, Norbert, 65719 Hofheim, DE<br />

C07K 14/80 → (51) C12N 15/53<br />

(51) C07K 16/00 (11) 1 695 985 B1<br />

C12N 15/13 C12N 15/73<br />

A61K 39/395<br />

(25) En (26) En<br />

(21) 05077948.7 (22) 03.04.1998<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

AL LT LV MK RO SI<br />

(43) 30.08.2006<br />

(30) 07.04.1997 US 833504<br />

(54) • Verfahren zur Herstellung humanisierter<br />

Antikörper durch randomisierte Mutagenese<br />

• Methods for forming humanised antibodies<br />

by random mutagenesis<br />

• Procédé pour la production d'anticorps<br />

humanisés par mutagénèse randomisé<br />

(73) Genentech, Inc., 1 DNA Way, South San<br />

Francisco CA 94080-4990, US<br />

(72) Wells, James A., Burlingame, CA 940<strong>10</strong>, US<br />

Baca, Manuel, Foster City, CA 94404, US<br />

Presta, Leonard G., San Francisco, CA<br />

94<strong>10</strong>9, US<br />

(74) Wichmann, Hendrik, et al, Wuesthoff &<br />

Wuesthoff Schweigerstrasse 2, 81541<br />

München, DE<br />

(62) 98918013.8 / 0 971 959<br />

C07K 16/00 → (51) C07K 19/00<br />

C07K 16/00 → (51) C12P 21/00<br />

(51) C07K 16/<strong>10</strong> (11) 1 749 029 B1<br />

A61K 39/395 A61P 31/14<br />

C12N 15/13 C12N 15/63<br />

C12N 5/<strong>10</strong><br />

(25) En (26) En<br />

(21) 05747901.6 (22) 26.05.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(43) 07.02.2007<br />

(86) EP 2005/0524<strong>10</strong> 26.05.2005<br />

(87) WO 2005/118644 2005/50 15.12.2005<br />

(30) 27.05.2004 PCT/EP2004/050943<br />

27.05.2004 US 575023 P<br />

29.07.2004 PCT/EP2004/051661<br />

23.09.2004 PCT/EP2004/052286<br />

03.11.2004 PCT/EP2004/052772<br />

25.01.2005 PCT/EP2005/0503<strong>10</strong><br />

03.03.2005 PCT/EP2005/050953<br />

(54) • BINDUNGSMOLEKÜLE, DIE DAZU FÄHIG<br />

SIND, DAS TOLLWUTVIRUS ZU NEUTRA-<br />

LISIEREN, UND ANWENDUNGEN DAVON<br />

• BINDING MOLECULES CAPABLE OF NEU-<br />

TRALIZING RABIES VIRUS AND USES<br />

THEREOF<br />

• MOLECULES DE LIAISON POUVANT NEU-<br />

TRALISER LE VIRUS DE LA RAGE ET<br />

UTILISATION<br />

(73) Crucell Holland B.V., Archimedesweg 4,<br />

2333 CN Leiden, NL<br />

593<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>10</strong>/<strong>2011</strong>) 09.03.<strong>2011</strong><br />

(72) BAKKER, Alexander, Berthold, Hendrik, NL-<br />

2182 GJ Hillegom, NL<br />

MARISSEN, Willem Egbert, NL-3448 BH<br />

Woerden, NL<br />

KRAMER, Robert Arjen, NL-3524 KV Utrecht,<br />

NL<br />

DE KRUIF, Cornelis Adriaan, NL-3731 EL De<br />

Bilt, NL<br />

(74) Verhage, Richard Abraham, et al, Crucell<br />

Holland B.V. P.O. Box 2048, 2301 CA Leiden,<br />

NL<br />

(60) <strong>10</strong>180375.7<br />

<strong>10</strong>180398.9<br />

C07K 16/12 → (51) A61K 39/09<br />

C07K 16/16 → (51) C12N 15/82<br />

C07K 16/18 → (51) C12N 15/12<br />

(51) C07K 16/28 (11) 1 583 558 B1<br />

C07K 16/46 C12N 15/13<br />

A61K 39/395 A61P 31/18<br />

(25) En (26) En<br />

(21) 03786626.6 (22) <strong>10</strong>.11.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 12.<strong>10</strong>.2005<br />

(86) US 2003/035758 <strong>10</strong>.11.2003<br />

(87) WO 2004/064724 2004/32 05.08.2004<br />

(30) 15.01.2003 US 342959<br />

(54) • MASSGESCHNEIDERTE ENTIMMUNI-<br />

SIERTE MONOKLONALE ANTIKÖRPER<br />

ZUM SCHUTZ GEGEN HIV-EINWIRKUNG<br />

UND ZUR BEHANDLUNG VON HIV-INFEK-<br />

TIONEN<br />

• DESIGNED DEIMMUNIZED MONOCLONAL<br />

ANTIBODIES FOR PROTECTION AGAINST<br />

HIV EXPOSURE AND TREATMENT OF HIV<br />

INFECTION<br />

• ANTICORPS MONOCLONAUX DESIMMU-<br />

NISES ARTIFICIELS UTILISES POUR LA<br />

PROTECTION CONTRE L'EXPOSITION AU<br />

VIH ET LE TRAITEMENT DE L'INFECTION<br />

PAR LE VIH<br />

(73) United Biomedical, Inc., 25 Davids Drive,<br />

Hauppauge, New York 11788, US<br />

United Biomedical Asia, 45 Kwang- Fu N.<br />

Road Huko, Hsin Chu Hsien 303, TW<br />

(72) LYNN, Shugene, Yangmei Jen, Taoyuan 326,<br />

TW<br />

WANG, Chang Yi, Cold Spring Harbor, NY<br />

11724, US<br />

(74) Strych, Werner Maximilian Josef, et al,<br />

Hansmann & Vogeser, <strong>Patent</strong>- und<br />

Rechtsanwälte, Albert-Rosshaupter-Strasse<br />

65, 81369 München, DE<br />

(51) C07K 16/28 (11) 1 708 961 B1<br />

C07K 16/46 A61K 39/395<br />

(25) En (26) En<br />

(21) 04800979.9 (22) <strong>10</strong>.11.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LU MC NL PL PT RO SE SI<br />

SK TR<br />

AL HR LT LV MK YU<br />

(43) 11.<strong>10</strong>.2006<br />

(86) US 2004/037600 <strong>10</strong>.11.2004<br />

(87) WO 2005/060457 2005/27 07.07.2005<br />

(30) 04.12.2003 US 527882 P<br />

07.05.2004 PCT/US2004/014507<br />

(54) • ANTI-IP-<strong>10</strong>-ANTIKÖRPER<br />

• ANTI-IP-<strong>10</strong> ANTIBODIES<br />

• ANTICORPS ANTI-IP<strong>10</strong><br />

(73) Abbott Biotherapeutics Corp., 1500 Seaport<br />

Boulevard, Redwood City CA 94063, US<br />

(72) BALASA, Balaji, Union City, CA 94587, US

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!